Lgi1 Autoimmune Encephalitis

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2025-05-31
Clinical Trial Update: A Study to Test the Efficacy, Safety, and Pharmacokinetics of Rozanolixizumab in Adult Study Participants With Leucine-Rich Glioma Inactivated 1 Autoimmune Encephalitis [Phase 2]
Phase 2 study of Rozanolixizumab in adults with LGI1 autoimmune encephalitis was terminated; results have been posted.